Skip to main content

Table 1 Patient characteristics

From: Implementation of a telephone-based secondary preventive intervention after acute coronary syndrome (ACS): participation rate, reasons for non-participation and 1-year survival

  Included Excluded Declined p p p
  N % or SD n % or SD n % or SD i/e i/d d/e
Subjects 661 72.9 146 16.1 100 11    
Gender (male) 453 68.5 80 54.8 47 53 0.002 <0.001 0.230
Mean age (years ± SD) 69.2 ± 11.9 76.3 ± 12.1 77.3 ± 11.7 <0.001 <0.001 0.499
Basic characteristics
mRS >3 7 1.1 33 22.6 8 8.0 <0.001 <0.001 0.003
eGFR 78.4 ± 21.3 68.9 ± 22.9 70.4 ± 21.5 <0.001 0.001 0.597
eGFR <60 128 19.4 52 35.6 29 29 <0.001 0.026 0.278
eGFR 60–90 308 46.6 66 45.2 50 50 0.76 0.525 0.459
eGFR >90 225 34.0 28 19.2 21 21 <0.001 0.009 0.725
BMI (mean ± SD) 27.3 ± 4.5 25.8 ± 5.2 26.4 ± 5 0.001 0.077 0.375
BMI <18.5 5 ± 0.8 14 ± 10.1 3 ± 3.1 <0.001 0.070 0.044
BMI 18.5–25 206 ± 31.2 49 ± 35.3 34 ± 35.1 0.347 0.442 0.975
BMI 25–30 295 ± 44.6 53 ± 38.1 39 ± 40.2 0.160 0.413 0.748
BMI >30 155 ± 23.4 23 ± 16.5 21 ± 21.6 0.075 0.695 0.322
Only basic education 345 52.2 99 67.8 77 77.0 <0.001 <0.001 0.231
Heredity (first line) 178 27.3 28 21.5 20 21.5 0.173 0.237 0.995
Previous morbidities
Previous IHD 156 23.6 51 34.9 34 34.0 0.005 0.025 0.880
Current NSTEMI 420 63.5 100 68.5 69 69.0 0.258 0.288 0.933
Current STEMI 182 27.5 42 28.8 25 25.0 0.763 0.596 0.514
Previous stroke 48 7.3 26 17.8 15 15.0 <0.001 0.009 0.562
Peripheral artery disease 15 2.3 8 5.5 5 5.0 0.035 0.112 0.869
Congestive heart failure CHF (Previous) 23 3.5 20 13.7 10 10.0 <0.001 0.003 0.384
Smoking (current/previous) 414 62.6 79 54.1 57 57.0 0.065 0.272 0.697
Atrial fibrillation 95 14.8 42 29.4 26 26.0 <0.001 0.002 0.701
Hyperlipidemia 463 96.1 110 96.5 80 100 0.829 0.071 0.090
Hypertension 354 53.6 95 65.1 67 67.0 0.011 0.012 0.754
Diabetes 135 20.4 45 30.8 28 28.0 0.006 0.085 0.634
  1. p values for comparison: i/e, included versus excluded; i/d, included versus declined; d/e, declined versus excluded. Hyperlipidemia: treatment initiated or untreated total cholesterol >4.5 mmol/L or untreated LDL cholesterol >2.5 mmol/L
  2. BMI body mass index, eGFR estimated glomerular filtration rate, IHD ischemic heart disease, LDL low-density lipoprotein, mRS modified Rankin scale, NSTEMI non-ST-elevation myocardial infarction, SD standard deviation, STEMI ST-elevation myocardial infarction